首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   109820篇
  免费   47513篇
  国内免费   2292篇
耳鼻咽喉   1920篇
儿科学   4866篇
妇产科学   1366篇
基础医学   19123篇
口腔科学   5999篇
临床医学   16349篇
内科学   27639篇
皮肤病学   7790篇
神经病学   14995篇
特种医学   3368篇
外国民族医学   14篇
外科学   17981篇
综合类   6447篇
现状与发展   7篇
一般理论   23篇
预防医学   7126篇
眼科学   1983篇
药学   9369篇
  39篇
中国医学   3305篇
肿瘤学   9916篇
  2024年   162篇
  2023年   715篇
  2022年   1658篇
  2021年   3387篇
  2020年   6551篇
  2019年   11989篇
  2018年   11316篇
  2017年   12624篇
  2016年   13124篇
  2015年   13663篇
  2014年   13970篇
  2013年   14565篇
  2012年   7224篇
  2011年   7189篇
  2010年   11085篇
  2009年   6987篇
  2008年   4122篇
  2007年   2816篇
  2006年   2677篇
  2005年   2234篇
  2004年   1820篇
  2003年   1738篇
  2002年   1682篇
  2001年   1467篇
  2000年   1283篇
  1999年   753篇
  1998年   275篇
  1997年   305篇
  1996年   231篇
  1995年   183篇
  1994年   195篇
  1993年   137篇
  1992年   204篇
  1991年   202篇
  1990年   179篇
  1989年   155篇
  1988年   140篇
  1987年   115篇
  1986年   92篇
  1985年   62篇
  1984年   49篇
  1983年   36篇
  1982年   21篇
  1981年   24篇
  1980年   31篇
  1979年   28篇
  1978年   22篇
  1977年   23篇
  1974年   14篇
  1970年   13篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
92.
Increasing evidence suggests that human epidermal melanocytes play an important role in the skin immune system; however, a role of their pigmentation in immune and inflammatory responses is poorly examined. In the study, the expression of Toll‐like receptor 4 (TLR4) and inflammatory cytokines and chemokines by cultured normal melanocytes derived from lightly and darkly pigmented skin was investigated after cell stimulation with lipopolysaccharide (LPS). The basal TLR4 mRNA level in heavily pigmented cells was higher as compared to their lightly pigmented counterparts. Melanocyte exposure to LPS upregulated the expression of TLR4 mRNA and enhanced the DNA‐binding activity of NF‐κB p50 and p65. We found substantial differences in the LPS‐stimulated expression of numerous genes encoding inflammatory cytokines and chemokines between the cells with various melanin contents. In lightly pigmented melanocytes, the most significantly upregulated genes were nicotinamide phosphoribosyltransferase (NAMPT/visfatin), the chemokines CCL2 and CCL20, and IL6, while the genes for CXCL12, IL‐16 and the chemokine receptor CCR4 were the most significantly upregulated in heavily pigmented cells. Moreover, the lightly pigmented melanocytes secreted much more NAMPT, CCL2 and IL‐6. The results of our study suggest modulatory effect of melanogenesis on the immune properties of normal epidermal melanocytes.  相似文献   
93.
94.

Background

Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.

Objectives

To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.

Methods

Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.

Results

Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.

Conclusions

These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study.  相似文献   
95.
96.
97.
98.
99.
100.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号